The annual study analyzes companies with revenues of more than $1 billion who filed their annual proxy statements by March 31.
The report found that median total compensation for Equilar 100 CEOs rose 7.7 percent from 2021 to 2022. This is significantly lower than the previous year’s increase of 30.8 percent from 2020 to 2021.
Nearly all pay components increased; cash bonuses were the exception, falling 5.9 percent in 2022. Median stock awards saw the steepest climb, increasing 19.7 percent to $13.8 million throughout the year.
CEO pay continues to rise at a faster rate than the median employee’s. The CEO-to-median-employee pay ratio was 288:1 in 2022, compared to 254:1.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
